PETER H. TSANG, MD
Osteopathic Medicine at Canal St, New York, NY

License number
New York 184591
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address 2
268 Canal St, New York, NY 10013
1403 Spring Ln, East Stroudsburg, PA 18301
Phone
(212) 379-6999
(212) 379-6936 (Fax)
(507) 476-1039

Professional information

Peter Tsang Photo 1

Peter Tsang

Work:
British Airways - New York, NY
Customer Service Agent
National Academy of Television Arts and Sciences - New York, NY
Emmy Consultant
Asan Office of Education
Public School Teacher
Weill Cornell Medical College - New York, NY
Inventory management
Education:
CUNY Hunter College - New York, NY
Bachelor of Arts in Economics
SUNY Stony Brook - New York, NY
Bachelors of Science in Biochemistry


Peter H Tsang Photo 2

Dr. Peter H Tsang, New York NY - MD (Doctor of Medicine)

Specialties:
Infectious Disease Medicine
Address:
268 Canal St, New York 10013
(212) 379-6988 (Phone), (212) 379-6936 (Fax)
Languages:
English, Chinese
Education:
Medical School
New York Medical College
Graduated: 1989
Cabrini Med Center
Mt Sinai School Of Med
Ny Hospital Med Center Of Queens
University Hospital SUNY Stony Brook


Peter Hinying Tsang Photo 3

Peter Hinying Tsang, New York NY

Specialties:
Internal Medicine, Infectious Disease
Work:
Charles B. Wang Community Health Ctr
268 Canal St, New York, NY 10013
Education:
New York Medical College (1989)


Peter Tsang Photo 4

Leukocyte Adherence Inhibition Assay

US Patent:
4455379, Jun 19, 1984
Filed:
Jul 21, 1981
Appl. No.:
6/285587
Inventors:
Julius G. Bekesi - Teaneck NJ
James F. Holland - Scarsdale NY
Peter H. Tsang - New York NY
Assignee:
Mount Sinai School of Medicine of the City University of New York - New York NY
International Classification:
G01N 3358, G01N 3360
US Classification:
436504
Abstract:
A new technique is disclosed for assaying for the presence of invasive cancer. While based on leukocyte adherence inhibition, it is improved by using relatively long lived radio-labeled leukocytes, fractionation of the leukocytes to separately treat T-cells and monocytes and by providing for human plasma or serum in the incubation medium.


Peter Tsang Photo 5

Leukocyte Adherence Inhibition Assay

US Patent:
4666834, May 19, 1987
Filed:
Mar 28, 1984
Appl. No.:
6/594231
Inventors:
Julius G. Bekesi - Teaneck NJ
James F. Holland - Scarsdale NY
Peter H. Tsang - New York NY
Assignee:
Mount Sinai School of Medicine of the City University of New York - New York NY
International Classification:
C12Q 102, G01N 33534
US Classification:
435 29
Abstract:
A new technique is disclosed for assaying for the presence of invasive cancer. While based on leukocyte adherence inhibition, it is improved by using relatively long lived radio-labeled leukocytes, fractionation of the leukocytes to separately treat T-cells and monocytes and by providing for human plasma or serum in the incubation medium.